1,25-Dihydroxyvitamin/NN
D3/NN
receptors/NNS
in/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
from/IN
patients/NNS
with/IN
renal/JJ
insufficiency/NN
./.

A/DT
reduced/VBN
expression/NN
of/IN
the/DT
vitamin/NN
D/NN
receptor/NN
(/(
VDR/NN
)/)
in/IN
parathyroid/JJ
glands/NNS
of/IN
uremic/JJ
animals/NNS
and/CC
humans/NNS
has/VBZ
been/VBN
observed/VBN
./.
=====
Similar/JJ
results/NNS
have/VBP
been/VBN
obtained/VBN
by/IN
our/PRP$
own/JJ
group/NN
in/IN
peripheral/JJ
blood/NN
mononuclear/JJ
cells/NNS
(/(
PBMC/NNS
)/)
from/IN
patients/NNS
with/IN
secondary/JJ
hyperparathyroidism/NN
to/TO
chronic/JJ
renal/JJ
failure/NN
./.
=====
However/RB
,/,
the/DT
reasons/NNS
for/IN
these/DT
changes/NNS
are/VBP
not/RB
clear/JJ
./.
=====
In/IN
the/DT
present/JJ
study/NN
,/,
we/PRP
have/VBP
investigated/VBN
the/DT
specific/JJ
uptake/NN
of/IN
[3H]1,25(OH)2D3/NN
by/IN
PBMC/NNS
of/IN
11/CD
women/NNS
with/IN
advanced/JJ
chronic/JJ
renal/JJ
failure/NN
(/(
A-CRF/NN
)/)
,/,
6/CD
women/NNS
with/IN
mild-moderate/JJ
renal/JJ
insufficiency/NN
(/(
M-CRF/NN
)/)
,/,
and/CC
23/CD
healthy/JJ
women/NNS
./.
=====
The/DT
mean/JJ
dissociation/NN
constant/NN
(/(
KD/NN
)/)
was/VBD
similar/JJ
in/IN
both/CC
groups/NNS
of/IN
patients/NNS
and/CC
in/IN
healthy/JJ
women/NNS
(/(
A-CRF/NN
:/:
0.7/CD
+/-/CC
0.5/CD
x/CC
10(-10)/CD
M/NN
;/:
M-CRF/NN
:/:
1.1/CD
+/-/CC
0.9/CD
x/CC
10(-10)/CD
M/NN
;/:
controls/NNS
:/:
1.0/CD
+/-/CC
0.6/CD
x/CC
10(-10)/CD
M/NN
)/)
./.
=====
However/RB
,/,
VDR/NN
concentration/NN
was/VBD
significantly/RB
decreased/VBN
in/IN
A-CRF/NN
(/(
0.8/CD
+/-/CC
0.5/CD
fmol/10(7)/NN
cells/NNS
vs./CC
2.3/CD
+/-/CC
0.9/CD
fmol/10(7)/NN
cells/NNS
in/IN
controls/NNS
,/,
p/NN
</JJR
0.001/CD
)/)
,/,
whereas/IN
no/DT
changes/NNS
were/VBD
seen/VBN
in/IN
M-CRF/NN
(/(
1.7/CD
+/-/CC
0.7/CD
fmol/10(7)/NN
cells/NNS
vs./CC
2.3/CD
+/-/CC
0.9/CD
fmol/10(7)/NN
cells/NNS
in/IN
controls/NNS
)/)
./.
=====
No/DT
correlation/NN
was/VBD
seen/VBN
between/IN
VDR/NN
and/CC
serum/NN
calcitriol/NN
or/CC
PTH/NN
levels/NNS
,/,
when/WRB
considering/VBG
both/DT
groups/NNS
of/IN
patients/NNS
together/RB
or/CC
separately/RB
./.
=====
Conversely/RB
,/,
a/DT
significant/JJ
negative/JJ
correlation/NN
was/VBD
found/VBN
between/IN
VDR/NN
and/CC
serum/NN
creatinine/NN
values/NNS
when/WRB
A-CRF/NN
and/CC
M-CRF/NN
were/VBD
considered/VBN
altogether/RB
(/(
r/NN
=/JJ
-0.63/CD
;/:
p/NN
</JJR
0.01/CD
)/)
./.
=====
Treatment/NN
with/IN
two/CD
different/JJ
schedules/NNS
of/IN
oral/JJ
calcitriol/NN
(/(
five/CD
patients/NNS
with/IN
0.5/CD
microgram/day/NNS
for/IN
1/CD
month/NN
and/CC
four/CD
patients/NNS
with/IN
2/CD
micrograms/day/NN
for/IN
7/CD
days/NNS
)/)
did/VBD
not/RB
change/VB
VDR/NN
concentrations/NNS
./.
=====
We/PRP
conclude/VBP
that/IN
the/DT
low/JJ
levels/NNS
of/IN
serum/NN
1,25(OH)2D3/NN
of/IN
uremia/NN
are/VBP
not/RB
responsible/JJ
for/IN
the/DT
decrease/NN
in/IN
VDR/NN
concentration/NN
found/VBN
in/IN
these/DT
patients/NNS
./.